Clinical Trials Directory

Trials / Terminated

TerminatedNCT00897377

Treatment Strategy for Low-grade Gliomas

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
500 (estimated)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Although the prognosis of patients with low-grade glioma (LGG) is generally good, recurrence seems unavoidable in some patients because of the infiltrative growth of the tumors. How to treat LGGs is still under controversy. The role of radiation therapy and chemotherapy in the treatment of LGG need to be further investigated. The purpose of this study is the following: 1. to investigate the role of early radiation therapy in MRI-determined total resected LGGs; 2. to compare the efficacy of early radiation therapy and that of initial chemotherapy in the LGGs without total resection.

Conditions

Interventions

TypeNameDescription
RADIATIONRadiation therapy
DRUGTemozolomide

Timeline

Start date
2007-12-01
First posted
2009-05-12
Last updated
2014-08-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT00897377. Inclusion in this directory is not an endorsement.